Syntheses of Morpholine-Based Nucleotide Analogs for Hepatic siRNA Targeting and Stabilization

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autorschaft

  • Armin Hofmeister
  • Kerstin Jahn-Hofmann
  • Bodo Brunner
  • Mike W. Helms
  • Christiane Metz-Weidmann
  • Arne Krack
  • Michael Kurz
  • Ziyu Li
  • Merle M. Weitzenberg
  • Elsa Pflimlin
  • Oliver Plettenburg
  • Sabine Scheidler

Organisationseinheiten

Externe Organisationen

  • Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
  • Hospices Civils de Lyon
  • Sanofi-Aventis Deutschland GmbH
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Seiten (von - bis)6838-6855
Seitenumfang18
FachzeitschriftJournal of medicinal chemistry
Jahrgang64
Ausgabenummer10
Frühes Online-Datum5 Mai 2021
PublikationsstatusVeröffentlicht - 27 Mai 2021

Abstract

A morpholine-based nucleotide analog was developed as a building block for hepatic siRNA targeting and stabilization. Attachment of an asialoglycoprotein-binding GalNAc ligand at the morpholine nitrogen was realized with different linkers. The obtained morpholino GalNAc scaffolds were coupled to the sense strand of a transthyretin-targeting siRNA and tested for their knockdown potency in vitro and in vivo. A clear structure-activity relationship was developed with regard to the linker type and length as well as the attachment site of the morpholino GalNAc moieties at the siRNA sense strand. Further, simple alkylation of the morpholine nitrogen led to a nucleotide analog, which increased siRNA stability, when used as a double 3′-overhang at the sense strand sequence. Combination of the best morpholino GalNAc building blocks as targeting nucleotides with an optimized stabilizing alkyl-substituted morpholine as 3′-overhangs resulted in siRNAs without any phosphorothioate stabilization in the sense strand and clearly improved the duration of action in vivo.

ASJC Scopus Sachgebiete

Zitieren

Syntheses of Morpholine-Based Nucleotide Analogs for Hepatic siRNA Targeting and Stabilization. / Hofmeister, Armin; Jahn-Hofmann, Kerstin; Brunner, Bodo et al.
in: Journal of medicinal chemistry, Jahrgang 64, Nr. 10, 27.05.2021, S. 6838-6855.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Hofmeister, A, Jahn-Hofmann, K, Brunner, B, Helms, MW, Metz-Weidmann, C, Krack, A, Kurz, M, Li, Z, Weitzenberg, MM, Pflimlin, E, Plettenburg, O & Scheidler, S 2021, 'Syntheses of Morpholine-Based Nucleotide Analogs for Hepatic siRNA Targeting and Stabilization', Journal of medicinal chemistry, Jg. 64, Nr. 10, S. 6838-6855. https://doi.org/10.1021/acs.jmedchem.1c00144
Hofmeister, A., Jahn-Hofmann, K., Brunner, B., Helms, M. W., Metz-Weidmann, C., Krack, A., Kurz, M., Li, Z., Weitzenberg, M. M., Pflimlin, E., Plettenburg, O., & Scheidler, S. (2021). Syntheses of Morpholine-Based Nucleotide Analogs for Hepatic siRNA Targeting and Stabilization. Journal of medicinal chemistry, 64(10), 6838-6855. https://doi.org/10.1021/acs.jmedchem.1c00144
Hofmeister A, Jahn-Hofmann K, Brunner B, Helms MW, Metz-Weidmann C, Krack A et al. Syntheses of Morpholine-Based Nucleotide Analogs for Hepatic siRNA Targeting and Stabilization. Journal of medicinal chemistry. 2021 Mai 27;64(10):6838-6855. Epub 2021 Mai 5. doi: 10.1021/acs.jmedchem.1c00144
Hofmeister, Armin ; Jahn-Hofmann, Kerstin ; Brunner, Bodo et al. / Syntheses of Morpholine-Based Nucleotide Analogs for Hepatic siRNA Targeting and Stabilization. in: Journal of medicinal chemistry. 2021 ; Jahrgang 64, Nr. 10. S. 6838-6855.
Download
@article{3bb3182e73cb474fb096f56f1264bd04,
title = "Syntheses of Morpholine-Based Nucleotide Analogs for Hepatic siRNA Targeting and Stabilization",
abstract = "A morpholine-based nucleotide analog was developed as a building block for hepatic siRNA targeting and stabilization. Attachment of an asialoglycoprotein-binding GalNAc ligand at the morpholine nitrogen was realized with different linkers. The obtained morpholino GalNAc scaffolds were coupled to the sense strand of a transthyretin-targeting siRNA and tested for their knockdown potency in vitro and in vivo. A clear structure-activity relationship was developed with regard to the linker type and length as well as the attachment site of the morpholino GalNAc moieties at the siRNA sense strand. Further, simple alkylation of the morpholine nitrogen led to a nucleotide analog, which increased siRNA stability, when used as a double 3′-overhang at the sense strand sequence. Combination of the best morpholino GalNAc building blocks as targeting nucleotides with an optimized stabilizing alkyl-substituted morpholine as 3′-overhangs resulted in siRNAs without any phosphorothioate stabilization in the sense strand and clearly improved the duration of action in vivo.",
author = "Armin Hofmeister and Kerstin Jahn-Hofmann and Bodo Brunner and Helms, {Mike W.} and Christiane Metz-Weidmann and Arne Krack and Michael Kurz and Ziyu Li and Weitzenberg, {Merle M.} and Elsa Pflimlin and Oliver Plettenburg and Sabine Scheidler",
year = "2021",
month = may,
day = "27",
doi = "10.1021/acs.jmedchem.1c00144",
language = "English",
volume = "64",
pages = "6838--6855",
journal = "Journal of medicinal chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "10",

}

Download

TY - JOUR

T1 - Syntheses of Morpholine-Based Nucleotide Analogs for Hepatic siRNA Targeting and Stabilization

AU - Hofmeister, Armin

AU - Jahn-Hofmann, Kerstin

AU - Brunner, Bodo

AU - Helms, Mike W.

AU - Metz-Weidmann, Christiane

AU - Krack, Arne

AU - Kurz, Michael

AU - Li, Ziyu

AU - Weitzenberg, Merle M.

AU - Pflimlin, Elsa

AU - Plettenburg, Oliver

AU - Scheidler, Sabine

PY - 2021/5/27

Y1 - 2021/5/27

N2 - A morpholine-based nucleotide analog was developed as a building block for hepatic siRNA targeting and stabilization. Attachment of an asialoglycoprotein-binding GalNAc ligand at the morpholine nitrogen was realized with different linkers. The obtained morpholino GalNAc scaffolds were coupled to the sense strand of a transthyretin-targeting siRNA and tested for their knockdown potency in vitro and in vivo. A clear structure-activity relationship was developed with regard to the linker type and length as well as the attachment site of the morpholino GalNAc moieties at the siRNA sense strand. Further, simple alkylation of the morpholine nitrogen led to a nucleotide analog, which increased siRNA stability, when used as a double 3′-overhang at the sense strand sequence. Combination of the best morpholino GalNAc building blocks as targeting nucleotides with an optimized stabilizing alkyl-substituted morpholine as 3′-overhangs resulted in siRNAs without any phosphorothioate stabilization in the sense strand and clearly improved the duration of action in vivo.

AB - A morpholine-based nucleotide analog was developed as a building block for hepatic siRNA targeting and stabilization. Attachment of an asialoglycoprotein-binding GalNAc ligand at the morpholine nitrogen was realized with different linkers. The obtained morpholino GalNAc scaffolds were coupled to the sense strand of a transthyretin-targeting siRNA and tested for their knockdown potency in vitro and in vivo. A clear structure-activity relationship was developed with regard to the linker type and length as well as the attachment site of the morpholino GalNAc moieties at the siRNA sense strand. Further, simple alkylation of the morpholine nitrogen led to a nucleotide analog, which increased siRNA stability, when used as a double 3′-overhang at the sense strand sequence. Combination of the best morpholino GalNAc building blocks as targeting nucleotides with an optimized stabilizing alkyl-substituted morpholine as 3′-overhangs resulted in siRNAs without any phosphorothioate stabilization in the sense strand and clearly improved the duration of action in vivo.

UR - http://www.scopus.com/inward/record.url?scp=85106494876&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.1c00144

DO - 10.1021/acs.jmedchem.1c00144

M3 - Article

C2 - 33950677

AN - SCOPUS:85106494876

VL - 64

SP - 6838

EP - 6855

JO - Journal of medicinal chemistry

JF - Journal of medicinal chemistry

SN - 0022-2623

IS - 10

ER -

Von denselben Autoren